Acute Radiation Syndrome Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Acute Radiation Syndrome Market is segmented By Radiation Type (Ionizing Radiation, Non-ionizing Radiation), By Product Type (Capsules, Tablets, Parenterals, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Billion) for the above-mentioned segments.
Competitive overview of Acute Radiation Syndrome Market
The major players operating in the Acute Radiation Syndrome Market include Statera BioPharma, NeoImmuneTech, Cellerant Therapeutics, Partner Therapeutics, Pluristem Therapeutics, Humanetics Corporation, Amgen, Recipharm AB, Mission Pharmacal Company, Partner Therapeutics, Novartis AG and Mylan NV.
Acute Radiation Syndrome Market Leaders
- Statera BioPharma
- NeoImmuneTech
- Cellerant Therapeutics
- Partner Therapeutics
- Pluristem Therapeutics
*Disclaimer: Major players are listed in no particular order.
Acute Radiation Syndrome Market - Competitive Rivalry, 2023
Acute Radiation Syndrome Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights